Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 4
1955 3
1956 26
1957 39
1958 37
1959 31
1960 16
1961 22
1962 51
1963 37
1964 38
1965 28
1966 36
1967 31
1968 35
1969 29
1970 31
1971 57
1972 55
1973 76
1974 85
1975 101
1976 87
1977 78
1978 71
1979 101
1980 79
1981 77
1982 73
1983 83
1984 89
1985 82
1986 88
1987 73
1988 93
1989 93
1990 61
1991 94
1992 73
1993 88
1994 75
1995 90
1996 100
1997 108
1998 121
1999 151
2000 144
2001 170
2002 222
2003 204
2004 214
2005 265
2006 310
2007 364
2008 368
2009 384
2010 380
2011 403
2012 430
2013 488
2014 471
2015 419
2016 435
2017 447
2018 394
2019 389
2020 389
2021 382
2022 250
Text availability
Article attribute
Article type
Publication date

Search Results

9,878 results
Results by year
Filters applied: . Clear all
Page 1
An update on the clinical pharmacology of methylphenidate: therapeutic efficacy, abuse potential and future considerations.
Shellenberg TP, Stoops WW, Lile JA, Rush CR. Shellenberg TP, et al. Expert Rev Clin Pharmacol. 2020 Aug;13(8):825-833. doi: 10.1080/17512433.2020.1796636. Epub 2020 Jul 25. Expert Rev Clin Pharmacol. 2020. PMID: 32715789 Review.
INTRODUCTION: Methylphenidate remains a first-line medication for treating ADHD in children and adults. ...The development of abuse deterrent formulations of methylphenidate is warranted....
INTRODUCTION: Methylphenidate remains a first-line medication for treating ADHD in children and adults. ...The development of abuse d …
Psychopharmacology of Attention-Deficit Hyperactivity Disorder: Effects and Side Effects.
Golmirzaei J, Mahboobi H, Yazdanparast M, Mushtaq G, Kamal MA, Hamzei E. Golmirzaei J, et al. Curr Pharm Des. 2016;22(5):590-4. doi: 10.2174/1381612822666151124235816. Curr Pharm Des. 2016. PMID: 26601963 Review.
Methylphenidate significantly reduces ADHD symptoms in children both at home and school and improves their social skills. Methylphenidate is safe in healthy children and has shown to have no cardiac side effects in these patients. ...
Methylphenidate significantly reduces ADHD symptoms in children both at home and school and improves their social skills. Methylph …
Classics in Chemical Neuroscience: Methylphenidate.
Wenthur CJ. Wenthur CJ. ACS Chem Neurosci. 2016 Aug 17;7(8):1030-40. doi: 10.1021/acschemneuro.6b00199. Epub 2016 Jul 25. ACS Chem Neurosci. 2016. PMID: 27409720 Review.
As the first drug to see widespread use for the treatment of attention deficit hyperactivity disorder (ADHD), methylphenidate was the forerunner and catalyst to the modern era of rapidly increasing diagnosis, treatment, and medication development for this condition. ...In …
As the first drug to see widespread use for the treatment of attention deficit hyperactivity disorder (ADHD), methylphenidate was the …
Pharmacokinetics and clinical effectiveness of methylphenidate.
Kimko HC, Cross JT, Abernethy DR. Kimko HC, et al. Clin Pharmacokinet. 1999 Dec;37(6):457-70. doi: 10.2165/00003088-199937060-00002. Clin Pharmacokinet. 1999. PMID: 10628897 Review.
Although ADHD has been widely studied, the use of methylphenidate in ADHD still poses a number of unresolved questions, including its pharmacodynamic characteristics (drug concentration-effect relationship) and the effect of long term treatment on the patient's psyc …
Although ADHD has been widely studied, the use of methylphenidate in ADHD still poses a number of unresolved questions, including its …
Comparison of the pharmacokinetics and clinical efficacy of new extended-release formulations of methylphenidate.
Maldonado R. Maldonado R. Expert Opin Drug Metab Toxicol. 2013 Aug;9(8):1001-14. doi: 10.1517/17425255.2013.786041. Epub 2013 Apr 23. Expert Opin Drug Metab Toxicol. 2013. PMID: 23611637 Review.
INTRODUCTION: Attention-deficit hyperactivity disorder (ADHD) is a common neurobehavioral disorder of which the main features are inattention, hyperactivity and impulsivity. Methylphenidate (MPH) is the mainstay of treatment, but its short duration of action and consequent …
INTRODUCTION: Attention-deficit hyperactivity disorder (ADHD) is a common neurobehavioral disorder of which the main features are inattentio …
Atomoxetine.
Unni JC. Unni JC. Indian Pediatr. 2006 Jul;43(7):603-6. Indian Pediatr. 2006. PMID: 16891679 Free article. Review. No abstract available.
Methylphenidate.
Manning FC. Manning FC. Tex Med. 1973 Jun;69(6):89-90. Tex Med. 1973. PMID: 4720632 No abstract available.
Effects of methylphenidate on reinforcement learning depend on working memory capacity.
Rostami Kandroodi M, Cook JL, Swart JC, Froböse MI, Geurts DEM, Vahabie AH, Nili Ahmadabadi M, Cools R, den Ouden HEM. Rostami Kandroodi M, et al. Psychopharmacology (Berl). 2021 Dec;238(12):3569-3584. doi: 10.1007/s00213-021-05974-w. Epub 2021 Oct 21. Psychopharmacology (Berl). 2021. PMID: 34676440 Free PMC article. Clinical Trial.
The paradigm was designed to disentangle effects on punishment avoidance from effects on reward perseveration. Given the known large individual variability in methylphenidate's effects, we stratified our effects by working memory capacity and trait impulsivity, puta …
The paradigm was designed to disentangle effects on punishment avoidance from effects on reward perseveration. Given the known large individ …
[All you need to know about methylphenidate (and dared not ask)].
Zimmer L, Fourneret P. Zimmer L, et al. Arch Pediatr. 2018 Apr;25(3):229-235. doi: 10.1016/j.arcped.2018.01.002. Epub 2018 Mar 12. Arch Pediatr. 2018. PMID: 29544968 French.
Methylphenidate (MPH) remains the only accessible psychostimulant used in France in the attention and behavior disturbances of attention deficit disorder with or without hyperactivity (ADHD). ...
Methylphenidate (MPH) remains the only accessible psychostimulant used in France in the attention and behavior disturbances of attent …
9,878 results